Retrospective studies indicate that active surveillance for clinically localized, small renal masses (cT1a, \<=4cm) is safe. It is our hypothesis that active surveillance is safe and efficacious when compared prospectively to patients undergoing immediate intervention for their small renal mass.
Kidney Neoplasm
Retrospective studies indicate that active surveillance for clinically localized, small renal masses (cT1a, \<=4cm) is safe. It is our hypothesis that active surveillance is safe and efficacious when compared prospectively to patients undergoing immediate intervention for their small renal mass.
The Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry
-
Johns Hopkins Hospital, Baltimore, Maryland, United States, 21287
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to 100 Years
ALL
Yes
Abramson Cancer Center at Penn Medicine,
Mohamad E Allaf, MD, MBA, PRINCIPAL_INVESTIGATOR, Johns Hopkins University
Nirmish Singla, PRINCIPAL_INVESTIGATOR, Johns Hopkins University
2026-01